(R)-2-(6-Fluoroimidazo[1,2-a]pyridin-3-yl)-9-(1-(5-fluoropyridin-2-yl)ethyl)-7H-purin-8(9H)-one

ID: ALA4536396

PubChem CID: 67123577

Max Phase: Preclinical

Molecular Formula: C19H13F2N7O

Molecular Weight: 393.36

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](c1ccc(F)cn1)n1c(=O)[nH]c2cnc(-c3cnc4ccc(F)cn34)nc21

Standard InChI:  InChI=1S/C19H13F2N7O/c1-10(13-4-2-11(20)6-22-13)28-18-14(25-19(28)29)7-24-17(26-18)15-8-23-16-5-3-12(21)9-27(15)16/h2-10H,1H3,(H,25,29)/t10-/m1/s1

Standard InChI Key:  ADCLIGYIOGFSIW-SNVBAGLBSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   23.7921  -13.6487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7909  -14.4682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4990  -14.8772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4972  -13.2398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2058  -13.6451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2061  -14.4637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9847  -14.7165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4657  -14.0540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9843  -13.3920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0887  -13.2406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7953  -12.9660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3423  -13.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2037  -12.2582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0062  -12.4309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5539  -11.8256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3046  -11.0442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5021  -10.8715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9490  -11.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2829  -14.0537    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.8537  -10.4390    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.2365  -12.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0358  -12.4445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5791  -13.0552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.3777  -12.8855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6306  -12.1076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0788  -11.4991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2823  -11.6719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6895  -12.0076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4297  -11.9363    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
 10 14  1  0
 13 11  2  0
 11 12  1  0
 12 10  2  0
  1 10  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
  8 19  2  0
 16 20  1  0
  9 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 21 28  1  6
 25 29  1  0
M  END

Associated Targets(Human)

JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO-K1 (1115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.36Molecular Weight (Monoisotopic): 393.1150AlogP: 2.72#Rotatable Bonds: 3
Polar Surface Area: 93.76Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.27CX Basic pKa: 4.92CX LogP: 2.91CX LogD: 2.91
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.41

References

1. Bach J, Eastwood P, González J, Gómez E, Alonso JA, Fonquerna S, Lozoya E, Orellana A, Maldonado M, Calaf E, Albertí J, Pérez J, Andrés A, Prats N, Carreño C, Calama E, De Alba J, Calbet M, Miralpeix M, Ramis I..  (2019)  Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases.,  62  (20): [PMID:31609613] [10.1021/acs.jmedchem.9b00533]

Source